These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37349993)

  • 1. Detection of Circulating Cell-free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-analysis.
    Aalami AH; Aalami F; Aliabadi EK; Amirabadi A; Sahebkar A
    Curr Med Chem; 2024; 31(22):3345-3359. PubMed ID: 37349993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of circulating cell-free DNA for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhang J; Yuan Y; Gao S; Zhao X; Li H
    Biomark Med; 2021 Feb; 15(3):219-239. PubMed ID: 33470842
    [No Abstract]   [Full Text] [Related]  

  • 3. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
    Zhang Z; Chen P; Xie H; Cao P
    Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
    Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.
    Liao W; Mao Y; Ge P; Yang H; Xu H; Lu X; Sang X; Zhong S
    Medicine (Baltimore); 2015 Apr; 94(14):e722. PubMed ID: 25860220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M
    Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis.
    Chen S; Zhang Y; Wu X; Zhang C; Li G
    Can J Gastroenterol Hepatol; 2018; 2018():8410195. PubMed ID: 30410873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysis.
    Yinzhong W; Miaomiao W; Xiaoxue T; Qian W; Meng Q; Junqiang L
    Expert Rev Mol Diagn; 2023 Jan; 23(1):63-69. PubMed ID: 36633401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
    Zhang J; Zhao Y; Yang Q
    Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
    Li JJ; Lv Y; Ji H
    PeerJ; 2022; 10():e14303. PubMed ID: 36348665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the diagnostic accuracy of heat shock proteins and their combination with Alpha-Fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis.
    Xiang D; Fu L; Yang Y; Liu C; He Y
    BMC Gastroenterol; 2024 May; 24(1):178. PubMed ID: 38773451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
    Oussalah A; Rischer S; Bensenane M; Conroy G; Filhine-Tresarrieu P; Debard R; Forest-Tramoy D; Josse T; Reinicke D; Garcia M; Luc A; Baumann C; Ayav A; Laurent V; Hollenbach M; Ripoll C; Guéant-Rodriguez RM; Namour F; Zipprich A; Fleischhacker M; Bronowicki JP; Guéant JL
    EBioMedicine; 2018 Apr; 30():138-147. PubMed ID: 29627389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma.
    Fu J; Li Y; Li Z; Li N
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29717027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data.
    Zhang WT; Gil-Gómez A; Liu CH; Gao SS; Romero-Gómez M
    Rev Esp Enferm Dig; 2022 May; 114(5):280-288. PubMed ID: 34423645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNAs as biomarkers for the diagnosis of hepatocellular carcinoma: A meta-analysis.
    Zeng C; Tang Y; Jiang Y; Zuo Z; Tao H
    Pathol Res Pract; 2021 Aug; 224():153546. PubMed ID: 34332221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging an Accurate Diagnostic Method for Hepatocellular Carcinoma? A Systematic Review with Meta-Analysis.
    Yinzhong W; Xiaoxue T; Jinhui T; Pengcheng Y; Xiaoying L; Junqiang L
    Curr Med Imaging; 2022; 18(6):633-647. PubMed ID: 34533447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis.
    Zhao ZH; Fan YC; Yang Y; Wang K
    World J Gastroenterol; 2013 Nov; 19(41):7189-96. PubMed ID: 24222965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.